We are live on ! Find out more
JSAM

J. Safra Asset Management Portfolio holdings

AUM $2.17B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.74%
1 Year Est. Return
+29.66%
3 Year Est. Return
+84.26%
5 Year Est. Return
+107.54%
10 Year Est. Return
AUM
$1.65B
AUM Growth
+$210M
Cap. Flow
+$87M
Cap. Flow %
5.28%
Top 10 Hldgs %
68.85%
Holding
505
New
138
Increased
161
Reduced
108
Closed
36

Sector Composition

Rank Sector Weight
1 Technology 3.5%
2 Communication Services 1.94%
3 Financials 1.1%
4 Consumer Discretionary 0.87%
5 Healthcare 0.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFN
251
PIMCO Income Strategy Fund II
PFN
$706M
$14.3K ﹤0.01%
+1,887
New +$14.2K
LAUR icon
252
Laureate Education
LAUR
$5.04B
$13.6K ﹤0.01%
432
-2,079
-83% -$54.5K
DUK icon
253
Duke Energy
DUK
$95.9B
$13.6K ﹤0.01%
+110
New +$13.3K
DD icon
254
DuPont de Nemours
DD
$19.4B
$13.3K ﹤0.01%
+136
New +$12.8K
PODD icon
255
Insulet
PODD
$10B
$13.3K ﹤0.01%
43
-5
-10% -$1.57K
FDX icon
256
FedEx
FDX
$76B
$13K ﹤0.01%
+55
New +$12.7K
GOF icon
257
Guggenheim Strategic Opportunities Fund
GOF
$2.27B
$12.6K ﹤0.01%
+843
New +$12.6K
MO icon
258
Altria Group
MO
$108B
$12.6K ﹤0.01%
+190
New +$12K
ASND icon
259
Ascendis Pharma A/S
ASND
$16.7B
$12.1K ﹤0.01%
61
-69
-53% -$12.9K
VZ icon
260
Verizon
VZ
$196B
$10.9K ﹤0.01%
+249
New +$10.8K
CME icon
261
CME Group
CME
$93.6B
$10.8K ﹤0.01%
+40
New +$10.9K
EXAS
262
DELISTED
Exact Sciences
EXAS
$10.7K ﹤0.01%
196
-27
-12% -$1.35K
IGR
263
CBRE Global Real Estate Income Fund
IGR
$706M
$10.3K ﹤0.01%
+2,000
New +$10.1K
FCX icon
264
Freeport-McMoran
FCX
$96.1B
$9.8K ﹤0.01%
+250
New +$10.8K
STZ icon
265
Constellation Brands
STZ
$22.6B
$9.7K ﹤0.01%
+72
New +$11.5K
BTSG icon
266
BrightSpring Health Services
BTSG
$11.5B
$9.49K ﹤0.01%
321
-370
-54% -$8.6K
STX icon
267
Seagate
STX
$186B
$9.44K ﹤0.01%
+40
New +$6.83K
CII icon
268
BlackRock Enhanced Captial and Income Fund
CII
$1.01B
$9.2K ﹤0.01%
+400
New +$8.8K
G icon
269
Genpact
G
$5.71B
$8.76K ﹤0.01%
209
-1,003
-83% -$44.1K
REGN icon
270
Regeneron Pharmaceuticals
REGN
$83.1B
$8.43K ﹤0.01%
+15
New +$8.48K
IGA
271
Voya Global Advantage and Premium Opportunity Fund
IGA
$158M
$8.41K ﹤0.01%
+848
New +$8.34K
IESC icon
272
IES Holdings
IESC
$15.1B
$8.35K ﹤0.01%
21
-93
-82% -$32K
INDA icon
273
iShares MSCI India ETF
INDA
$6.6B
$8.33K ﹤0.01%
+160
New +$8.56K
IRM icon
274
Iron Mountain
IRM
$36.4B
$8.15K ﹤0.01%
+80
New +$7.71K
ORLY icon
275
O'Reilly Automotive
ORLY
$75.1B
$8.09K ﹤0.01%
+75
New +$7.54K

Similar funds

J. Safra Asset Management's Q3 2025 Portfolio in Review

As of Q3 2025, J. Safra Asset Management held 505 positions worth $1.65B, up 15% from $1.44B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

J. Safra Asset Management deployed $87M of net new capital in Q3 2025, opening 138 new positions and adding to 161 existing holdings. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 1,011,916 shares worth $72.2M.

By sector, the portfolio is most concentrated in Technology at 3.5% of assets, up from 2.8% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was Invesco S&P 500 Equal Weight ETF, an estimated $43.4M trimmed.

  • J. Safra Asset Management's largest Q3 2025 buy was Vanguard FTSE All-World ex-US ETF: 1,011,916 shares worth $72.2M.
  • J. Safra Asset Management added most to State Street Technology Select Sector SPDR ETF in Q3 2025, an estimated $9.43M increase.
  • J. Safra Asset Management's biggest Q3 2025 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $43.4M.
  • J. Safra Asset Management fully exited iShares Ultra Short Duration Bond Active ETF in Q3 2025, selling an estimated $895K.
  • J. Safra Asset Management's ten largest holdings make up 69% of its $1.65B portfolio in Q3 2025.
  • J. Safra Asset Management opened 138 new positions and closed 36 in Q3 2025.
  • J. Safra Asset Management's portfolio value rose 15% quarter-over-quarter to $1.65B.

Based on J. Safra Asset Management's 13F filing for Q3 2025, filed 29 Oct 2025.